Paper5809587
Phosphonomycin, a new antibiotic produced by strains of streptomyces.
Hendlin D and 13 others. Science, 1969. Cited by 434 papers, by iCite.
Cite this record
ConductScience Library. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Papers, record 5809587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5809587
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Infections | Major topic |
| Streptomyces | Major topic |
| Animals | |
| Bacteria | |
| Cell Wall | |
| Mice |
Source PubMed
Cited by189
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 434 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42598483 | What's in a Name? Etymology and History of Antibacterials and Antifungals. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42598483 | PubMed |
| 42544122 | Fosfomycin Resistance in Escherichia coli: Mechanisms, Trends, and Clinical Challenges. | Cureus | 2026 | https://conductscience.org/library/papers/42544122 | PubMed |
| 42354795 | From Discovery to Manufacturing: A Quantitative Review of Phosphonates and Strategies for High-Titer Production. | Microorganisms | 2026 | https://conductscience.org/library/papers/42354795 | PubMed |
| 42005840 | H-phosphinic analogs of natural amino acids: a novel and efficient treatment for preventing biodeterioration of treasured painted artworks. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42005840 | PubMed |
| 41748715 | Five-decade global expansion of Staphylococcus argenteus ST2250 shapes antimicrobial resistance dynamics. | NPJ Antimicrob Resist | 2026 | https://conductscience.org/library/papers/41748715 | PubMed |
| 41599013 | Fosfomycin Resistance: An Update on the Anthropogenic Impact Through Agriculture. | Pathogens | 2025 | https://conductscience.org/library/papers/41599013 | PubMed |
| 41341494 | Overcoming the drug resistance barrier: progress in fosfomycin combination therapy against multidrug-resistant pathogens. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41341494 | PubMed |
| 41301599 | Fosfomycin in Complicated Intra-Abdominal Infections in an Intensive Care Setting: Does It Improve the Outcome? A Retrospective Observational Study. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41301599 | PubMed |
| 41041198 | From treating UTI to agranulocytosis. | J Family Med Prim Care | 2025 | https://conductscience.org/library/papers/41041198 | PubMed |
| 40191084 | High prevalence of plasmid-mediated Fosfomycin resistance in waterfowl-derived Escherichia coli strains: insights into genetic context and transmission dynamics in China. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40191084 | PubMed |
| 40134785 | Characterization of FosA13, a novel fosfomycin glutathione transferase identified in a Morganella morganii isolate from poultry. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40134785 | PubMed |
| 39907466 | Antimicrobial susceptibilities of clinical bacterial isolates from urinary tract infections to fosfomycin and comparator antibiotics determined by agar dilution method and automated micro broth dilution. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/39907466 | PubMed |
| 39606651 | Antibiotic efficacy and resistance patterns of urinary tract infection-causing bacteria in dogs and resistome of multidrug-resistant Klebsiella pneumoniae via whole genome sequencing in South Korea. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39606651 | PubMed |
| 39596744 | Fosfomycin-Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing Methods. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39596744 | PubMed |
| 39413156 | Molecular basis for the transcriptional regulation of an epoxide-based virulence circuit in Pseudomonas aeruginosa. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/39413156 | PubMed |
| 39282196 | The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review. | Indian J Microbiol | 2024 | https://conductscience.org/library/papers/39282196 | PubMed |
| 39207806 | Copper-Catalysed Synthesis of (E)-Allylic Organophosphorus Derivatives: A Low Toxic, Mild, Economical, and Ligand-Free Method. | ChemSusChem | 2025 | https://conductscience.org/library/papers/39207806 | PubMed |
| 39205651 | Population pharmacokinetics of oral fosfomycin calcium in healthy women. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39205651 | PubMed |
| 39200016 | A Novel Bacitracin-like Peptide from Mangrove-Isolated Bacillus paralicheniformis NNS4-3 against MRSA and Its Genomic Insights. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39200016 | PubMed |
| 38683856 | Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis. | PLoS Biol | 2024 | https://conductscience.org/library/papers/38683856 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5809587
GET https://conductscience.org/api/papers/v1/5809587/cited_by?page=2